A case-control study of menopausal estrogen therapy and breast cancer. 1980

R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson

The association between estrogen replacement therapy and female breast cancer was studied in two Los Angeles area retirement communities. The 138 study cases of breast cancer occurring in residents younger than 75 years were compared with age- and race-matched community control subjects. The risk ratio for a total cumulative dose in excess of 1,500 mg was estimated to be 2.5 in women with intact ovaries. This increase was present using various independent sources of drug usage information but was inconsistent at low dose and undetectable in oophorectomized women. No important sources of confounding could be identified, and no risk modifiers could be identified except for a history of surgically confirmed benign breast disease. In such women with intact ovaries, the risk ratio for a high cumulative dose rose to 5.7 relative to nonusers with normal breasts.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
January 1991, Archives of internal medicine,
R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
January 2018, JAMA,
R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
October 1992, Ugeskrift for laeger,
R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
January 2018, JAMA,
R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
January 2000, JAMA,
R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
July 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
January 1995, Cancer,
R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
January 2013, PloS one,
R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
November 1986, British journal of cancer,
R K Ross, and A Paganini-Hill, and V R Gerkins, and T M Mack, and R Pfeffer, and M Arthur, and B E Henderson
November 1994, Cancer causes & control : CCC,
Copied contents to your clipboard!